Aspira Pathlab & Diagnostics Ltd.
| BSE: 540788 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE500C01017 |
| BSE 00:00 | 15 Jul | 36.20 |
0 (0.00%) |
OPEN
36.20 |
HIGH
36.20 |
LOW
36.20 |
| NSE 05:30 | 01 Jan | Aspira Pathlab & Diagnostics Ltd |
| OPEN | 36.20 |
| PREVIOUS CLOSE | 36.20 |
| VOLUME | 5000 |
| 52-Week high | 36.20 |
| 52-Week low | 20.00 |
| P/E | 27.01 |
| Mkt Cap.(Rs cr) | 37 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Aspira Pathlab & Diagnostics Ltd. (ASPIRAPATHLAB) - Announcements
-
Aspira Pathlab & Diagnostics Ltd Shareholding for the Period Ended June 30 2021
13/07/2021 | bse
-
Aspira Pathlab & Diagnostics Ltd Statement Of Investor Complaints For The Quarter Ended June 2021
10/07/2021 | bse
-
Aspira Pathlab & Diagnostics Ltd Updates Regarding Extension Of Scope Of NABL Accreditation
10/07/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09/07/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange
02/07/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Closure of Trading Window
30/06/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regu
05/06/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Resignation of Director
05/06/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Resignation of Director
05/06/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Announcement under Regulation 30 (LODR)-Resignation of Director
05/06/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Outcome Of Board Meeting Held On June 5 2021
05/06/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Results- Audited Financial Results For Year Ended 31.3.2021
05/06/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing
28/05/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
10/05/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
10/05/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
26/04/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Shareholding for the Period Ended March 31 2021
20/04/2021 | bse
-
Aspira Pathlab & Diagnostics Ltd Certificate Under Regulation 40(10) Of Securities And Exchange Board Of India (Listing Obligations A
13/04/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Compliance-Compliance Certificate For Period Ended March 31 2021
09/04/2021 | bse |
Downlaod PDF -
Aspira Pathlab & Diagnostics Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09/04/2021 | bse |
Downlaod PDF
Quick Links for Aspira Pathlab & Diagnostics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
